We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

SWK Holdings Corp (SWKH) USD0.001

Sell:$6.95 Buy:$27.79 Change: $0.16 (0.92%)
Market closed |  Prices as at close on 17 July 2024 | Switch to live prices |
Sell:$6.95
Buy:$27.79
Change: $0.16 (0.92%)
Market closed |  Prices as at close on 17 July 2024 | Switch to live prices |
Sell:$6.95
Buy:$27.79
Change: $0.16 (0.92%)
Market closed |  Prices as at close on 17 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

SWK Holdings Corporation is engaged in specialty finance and asset management business. The Company’s segments include Finance Receivables and Pharmaceutical Development. Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Its Pharmaceutical Development segment operates through its subsidiary Enteris BioPharma, Inc. (Enteris). Enteris is a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its oral drug delivery technologies, the Peptelligence platform.

Contact details

Address:
5956 Sherry Lane, Suite 650
DALLAS
75225
United States
Telephone:
+1 (214) 2177253
Website:
https://www.swkhold.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
SWKH
ISIN:
US78501P2039
Market cap:
$214.28 million
Shares in issue:
12.47 million
Sector:
Specialized Finance
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Joe Staggs
    President, Chief Executive Officer
  • Adam Rice
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.